Home › Funds › Atle Fund Management AB › EW

Atle Fund Management AB position in EW

EDWARDS LIFESCIENCES CORP · Health Care

Atle Fund Management AB reported holding 109,647 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$9.5M, representing 2.53% of its reported portfolio and ranking #15 among its reported holdings. Atle Fund Management AB has disclosed EW holdings in 11 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)109.65K sh
Reported value held$9.46M
Portfolio Weight2.53%
First reportedQ4 2023
Last changeAdd
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Atle Fund Management AB's EW position evolved

Atle Fund Management AB first disclosed a stake in EW in Q4 2023 at 20,815 shares (US$1.6M). The position peaked in Q3 2026 at 109,647 shares, worth US$9.5M. Across 11 filings, Atle Fund Management AB increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 109,647 shares valued at US$9.5M — an increase of 6,417 shares quarter over quarter.. Notable position changes include a 47% increase in Q2 2024 (shares fell 29% over the following quarter), a 87% increase in Q4 2024 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 20.82K $1.59M New
Q1 2024 24.77K $2.37M Add
Q2 2024 36.51K $3.37M Add
Q3 2024 36.51K $2.41M Hold
Q4 2024 68.30K $5.07M Add
Q1 2025 59.70K $4.33M Reduce
Q2 2025 57.36K $4.49M Reduce
Q3 2025 65.66K $542.11K Add
Q1 2026 106.52K $8.27M New
Q2 2026 103.23K $9.34M Reduce
Q3 2026 109.65K $9.46M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 34 other funds we track also report a position in EW — the largest reported positions include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B), Aristotle Capital Management, LLC (US$783.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has Atle Fund Management AB held EW?

Atle Fund Management AB has disclosed EW holdings in 11 of the last 12 reported quarters, going back to Q4 2023.

What is Atle Fund Management AB's current position in EW?

As of Q3 2026, Atle Fund Management AB holds 109.65K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $9.46M, representing 2.53% of its reported portfolio and ranking #15.

Has Atle Fund Management AB been buying or selling EW?

In the latest 13F filing (Q3 2026), Atle Fund Management AB increased its position in EW. The position peaked in Q3 2026 at 109.65K shares.

Which other funds hold EW?

Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, Aristotle Capital Management, LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.